|
Market Closed -
Euronext Bruxelles
11:55:00 2026-08-21 EDT
|
After hours 15:59:59 | |||
| 221.70 EUR | +1.74% |
|
221.50 | -0.09% |
| 08-20 | Cancer vaccines finally garner the spotlight |  |
| 08-19 | Danish Pharma H. Lundbeck Expects No Slowdown for Primary Growth Driver Brands | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 48.52B | |||||
| 82.54B | |||||
| 58.38B | |||||
| 53.23B | - | ||||
| 52.24B | |||||
| 31.67B |
- Stock Market
- Stocks
- UCB Stock
- Charts UCB
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
